Uncategorized

Feature Panel: Going global – Funding and commercialising Australian innovation on the worldwide stage – Moderator: Nathan Simiana, Deloitte– Marc Kennis, Pitt Street Research– James Berman, Bell Potter– Paula Adamson, Wrays– James Walker, Scalare Partners– Mike Nicholls, Main Sequence Ventures– Pat Stewart, Radium

PYC Therapeutics (ASX:PYC) has announced plans to advance its investigational drug candidate, PYC-003, into human clinical trials for Autosomal Dominant Polycystic Kidney Disease (PKD) in early 2025. This decision follows the completion of pre-clinical studies demonstrating safety, efficacy, and targeted delivery in animal models and patient-derived kidney cysts. PKD is a genetic disorder that causes

Web Travel Group (ASX:WEB) has reported mixed results for the half-year ending 30 September 2024, its first reporting period since the demerger of its B2C businesses. The demerger, finalised on 30 September, saw Web Travel retain its WebBeds B2B travel marketplace, while Webjet Group, now operating separately, took over the B2C divisions, including Webjet OTA

Web Travel Group (ASX:WEB) has reported mixed results for the half-year ending 30 September 2024, its first reporting period since the demerger of its B2C businesses. The demerger, finalised on 30 September, saw Web Travel retain its WebBeds B2B travel marketplace, while Webjet Group, now operating separately, took over the B2C divisions, including Webjet OTA

VeriQuantix, a new cybersecurity company, specializes in Quantum Link Verification, a cutting-edge technology designed to secure fiber optic communication networks. CEO Peter Baynes highlights the vulnerabilities of current fiber optic systems, especially in the “last mile,” where data breaches often go undetected. The company’s solution uses quantum principles, specifically entangled photons, to verify the trustworthiness

VeriQuantix, a new cybersecurity company, specializes in Quantum Link Verification, a cutting-edge technology designed to secure fiber optic communication networks. CEO Peter Baynes highlights the vulnerabilities of current fiber optic systems, especially in the “last mile,” where data breaches often go undetected. The company’s solution uses quantum principles, specifically entangled photons, to verify the trustworthiness

Novonix (ASX:NVX) has completed a fully underwritten $44.4m institutional placement, issuing approximately 74.1 million new shares at $0.60 each. The placement, aimed at institutional and sophisticated investors, was well-supported by existing shareholders and welcomed several new investors. Chairman Admiral Robert J Natter noted, “The support from institutional shareholders and major backer Phillips 66 highlights confidence

Novonix (ASX:NVX) has completed a fully underwritten $44.4m institutional placement, issuing approximately 74.1 million new shares at $0.60 each. The placement, aimed at institutional and sophisticated investors, was well-supported by existing shareholders and welcomed several new investors. Chairman Admiral Robert J Natter noted, “The support from institutional shareholders and major backer Phillips 66 highlights confidence

Empire Energy Group (ASX:EEG) has been on a roll recently, announcing approval of its environmental management plan and the commencement of drilling. Today, the company announced the execution of binding commitment letters with Macquarie Bank for a $65m financing package to advance the Beetaloo Basin projects. The funding comprises three facilities designed to support key initiatives,

Orthocell (ASX:OCC) has appointed Device Technologies Asia (DVT Asia) as the exclusive distributor of its nerve repair device, Remplir, in Singapore. This marks the product’s first major international expansion beyond Australia and New Zealand, where sales have shown significant growth. Orthocell is a regenerative medicine company focused on repairing bone and soft tissue injuries. Remplir,